| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wright David K. | Chief Executive Officer, Director, 10%+ Owner | C/O PATTERN GROUP INC., 1441 WEST INNOVATION WAY, SUITE 500, LEHI | DAVID K. WRIGHT By: /s/ Allison Fletcher, Attorney-in-Fact for David K. Wright | 24 Sep 2025 | 0002086238 |
| Alder Melanie | Chief Strategy Officer, Director, 10%+ Owner | C/O PATTERN GROUP INC., 1441 WEST INNOVATION WAY, SUITE 500, LEHI | MELANIE ALDER By: /s/ Allison Fletcher, Attorney-in-Fact for Melanie Alder | 24 Sep 2025 | 0002085981 |
| Wright Irrevocable Trust | 10%+ Owner | C/O PATTERN GROUP INC., 1441 WEST INNOVATION WAY, SUITE 500, LEHI | WRIGHT IRREVOCABLE TRUST By: /s/ Allison Fletcher, Attorney-in-Fact for David K. Wright, Trustee By: /s/ Allison Fletcher, Attorney-in-Fact for Melanie Alder, Trustee | 24 Sep 2025 | 0002086236 |
| Alder Irrevocable Trust | 10%+ Owner | C/O PATTERN GROUP INC., 1441 WEST INNOVATION WAY, SUITE 500, LEHI | ALDER IRREVOCABLE TRUST By: /s/ Allison Fletcher, Attorney-in-Fact for David K. Wright, Trustee By: /s/ Allison Fletcher, Attorney-in-Fact for Melanie Alder, Trustee | 24 Sep 2025 | 0002085975 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PTRN | Common Stock | Other | -292,781 | -100% | 0 | 22 Sep 2025 | Direct | F1 | ||
| transaction | PTRN | Series A Common Stock | Other | +292,781 | 292,781 | 22 Sep 2025 | Direct | F1 | |||
| transaction | PTRN | Common Stock | Other | -97,593 | -100% | 0 | 22 Sep 2025 | By spouse | F1, F2 | ||
| transaction | PTRN | Series A Common Stock | Other | +97,593 | 97,593 | 22 Sep 2025 | By spouse | F1, F2 | |||
| transaction | PTRN | Series A Common Stock | Other | +50,991,951 | 50,991,951 | 22 Sep 2025 | By Wright Irrevocable Trust | F3, F4 | |||
| transaction | PTRN | Series A Common Stock | Sale | $74,144,616 | -5,694,671 | -11% | $13.02 | 45,297,280 | 22 Sep 2025 | By Wright Irrevocable Trust | F4, F5 |
| transaction | PTRN | Series A Common Stock | Other | +33,138,200 | 33,138,200 | 22 Sep 2025 | By Alder Irrevocable Trust | F3, F6 | |||
| transaction | PTRN | Series A Common Stock | Sale | $48,429,387 | -3,719,615 | -11% | $13.02 | 29,418,585 | 22 Sep 2025 | By Alder Irrevocable Trust | F5, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PTRN | Founder Non-Voting Preferred Stock | Other | -41,817,539 | -100% | 0 | 22 Sep 2025 | See footnotes | 50,991,951 | By Wright Irrevocable Trust | F3, F4, F7 | |||
| transaction | PTRN | Founder Non-Voting Preferred Stock | Other | -27,176,014 | -100% | 0 | 22 Sep 2025 | See footnotes | 33,138,200 | By Alder Irrevocable Trust | F3, F6, F7 | |||
| transaction | PTRN | Founder Voting Preferred Stock | Other | -10,682,278 | -100% | 0 | 22 Sep 2025 | See footnotes | 13,025,878 | Direct | F8, F9 | |||
| transaction | PTRN | Series B Common Stock | Other | +13,025,878 | 13,025,878 | 22 Sep 2025 | Series A Common Stock | 13,025,878 | Direct | F9, F10 | ||||
| transaction | PTRN | Founder Voting Preferred Stock | Other | -7,115,543 | -100% | 0 | 22 Sep 2025 | See footnotes | 8,676,632 | By spouse | F2, F8, F9 | |||
| transaction | PTRN | Series B Common Stock | Other | +8,676,632 | 8,676,632 | 22 Sep 2025 | Series A Common Stock | 8,676,632 | By spouse | F2, F9, F10 |
| Id | Content |
|---|---|
| F1 | Pursuant to a reclassification exempt under Rule 16b-7 of the Securities Exchange Act of 1934, as amended, each share of Common Stock, $0.001 par value per share ("Common Stock"), was reclassified into one share of Series A Common Stock, $0.001 par value per share ("Series A Common Stock"), immediately prior to the completion of the Issuer's initial public offering of Series A Common Stock (the "Offering"). |
| F2 | David K. Wright's spouse, Melanie Alder, is a director and the Chief Strategy Officer of the Issuer. |
| F3 | Each share of Founder Non-Voting Preferred Stock was reclassified into 1.219391493 shares of Series A Common Stock immediately prior to the completion of the Offering. |
| F4 | These shares are owned directly by the Wright Irrevocable Trust dated December 5, 2019, of which David K. Wright and his spouse, Melanie Alder, are trustees. Each of David K. Wright and Melanie Alder disclaims beneficial ownership of these securities, except to the extent, if any, of their pecuniary interest therein, and the filing of this Form 4 is not an admission that any person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F5 | The shares were sold in the Offering pursuant to an underwriting agreement by and among the Issuer, the representatives of the underwriters and the selling stockholders named therein, dated September 18, 2025. The price of $13.02 represents the $14.00 Offering price per share of Series A Common Stock of the Issuer less the underwriting discounts and commissions of $0.98 per share, for shares sold to the underwriters pursuant to the Offering. |
| F6 | These shares are owned directly by the Alder Irrevocable Trust dated December 5, 2019, of which David K. Wright and his spouse, Melanie Alder, are trustees. Each of David K. Wright and Melanie Alder disclaims beneficial ownership of these securities, except to the extent, if any, of their pecuniary interest therein, and the filing of this Form 4 is not an admission that any person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F7 | Each share of Founder Non-Voting Preferred Stock was convertible into, subject to certain anti-dilution adjustments dependent on the Offering price, (i) one share of Common Stock or (ii) in contemplation of an Offering, one share of Founder Voting Preferred Stock, at any time at the option of the holder. The shares of Founder Non-Voting Preferred Stock had no expiration date. |
| F8 | Each share of Founder Voting Preferred Stock was convertible into, subject to certain anti-dilution adjustments dependent on the Offering price, (i) one share of Common Stock or (ii) one share of Founder Non-Voting Preferred Stock, at any time at the option of the holder. The shares of Founder Voting Preferred Stock had no expiration date. |
| F9 | Each share of Founder Voting Preferred Stock was reclassified into 1.219391493 shares of Series B Common Stock immediately prior to the completion of the Offering. |
| F10 | Each share of Series B Common Stock is convertible into one share of Series A Common Stock at the option of the holder at any time. Each share of Series B Common Stock will automatically convert into one share of Series A Common Stock upon certain transfers and the occurrence of certain events described in the Issuer's amended and restated certificate of incorporation. |